Introduction {#s1}
============

Regular physical exercise has widespread beneficial effects on multiple body systems in healthy individuals and increases quality of life and lifespan. It is one of the most effective ways of preventing cardiovascular disease through reduction in risk factors such as obesity, hypertension and metabolic syndrome and by enhancing vascular function ([@bib17]). Regular exercise also reduces morbidity and mortality in conditions such as chronic heart failure and dementia ([@bib36]). Fundamental to these beneficial effects of exercise is the capacity of the heart to substantially increase its performance and output during exercise, safely and without detriment to the heart itself. The intrinsic mechanisms that underlie the physiological adaptation of the heart to regular exercise are therefore crucial to its overall beneficial effects ([@bib40]).

Previous studies show that intrinsic pathways that mediate cardiac adaptive responses to exercise are triggered rapidly, even after just 1--3 bouts of consecutive exercise, and are sufficiently robust to provide significant cardioprotection ([@bib5]; [@bib25]). Among the candidate pathways involved in the adaptive response to acute exercise are those that maintain a balance between reactive oxygen species (ROS) and endogenous antioxidant defences. The maintenance of a physiological redox state is crucial for all cellular functions and is likely to be especially important when cardiac workload and the activity of metabolic pathways that support it are changing rapidly during exercise. Myocardial ROS levels rise transiently during acute exercise ([@bib20]), which is thought to be related to enhanced activity of the mitochondrial respiratory chain during increases in cardiac contractility. Excessive levels of ROS (oxidative stress) could cause damage to membranes, proteins and DNA and lead to detrimental consequences such as mitochondrial, metabolic and cellular dysfunction. However, these potentially detrimental effects are limited by endogenous antioxidant defences, and exercise has been found to increase antioxidant capacity in the heart and skeletal muscle ([@bib26]; [@bib28]). Interestingly, low-level increases in ROS may themselves induce a response that counteracts oxidative stress (termed hormesis), which represents a physiological adaptive mechanism ([@bib28]). However, the sources of ROS that may be involved and their regulatory roles in this process remain elusive.

Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor which is a master regulator of cellular redox balance. It binds to antioxidant response elements (AREs) in the promoter regions of its target genes which include enzymes involved in glutathione biosynthesis and maintenance such as glutamate-cysteine ligase catalytic subunit (GCLC) and glutathione reductase; antioxidant enzymes such as catalase (CAT), thioredoxin reductases (TRXRs) and haem oxygenase-1, and detoxification enzymes such as NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione S-transferases (GSTs) ([@bib22]). Nrf2 normally undergoes rapid turnover through ubiquitination and proteosomal degradation. However, upon exposure to oxidants or electrophiles, its associated protein Keap1 is modified and enables Nrf2 to be stabilised and then accumulate in the nucleus to mediate gene transcription. Previous work implicates the upregulation of Nrf2 and endogenous antioxidant defences as an adaptive response to exercise in heart and skeletal muscle ([@bib7]; [@bib20]; [@bib23]; [@bib41]).

NADPH oxidase-4 (Nox4) is a member of the Nox family proteins, which generate ROS by catalysing electron transfer from NADPH to molecular O~2~ ([@bib13]). Unlike other ROS sources such as mitochondria, uncoupled nitric oxide synthases and xanthine oxidases, the Nox enzymes produce ROS as their primary function and have been shown to be involved in diverse redox signalling pathways. In contrast to other mammalian Nox isoforms, Nox4 is constitutively active and is regulated mainly by its abundance ([@bib43]). Previous studies show that cardiac Nox4 levels rise in response to diverse cellular stresses ([@bib13]; [@bib42]), in part as a transcriptional response to ATF4 ([@bib32]). In the disease setting of chronic pressure overload, the upregulation of Nox4 promotes adaptive cardiac remodelling through effects that include a preservation of myocardial capillary density ([@bib42]; [@bib45]) and an Nrf2-dependent enhancement of myocardial redox state ([@bib39]). However, it is not known whether Nox4 plays any physiological role in the heart.

Here, we report that cardiomyocyte Nox4 is an essential mediator of the physiological activation of the Nrf2 pathway during acute exercise, triggering an adaptive response that preserves redox balance, mitochondrial function and exercise performance. Our findings identify a novel physiological pathway that is required for the heart to safely and efficiently support physical exercise.

Results {#s2}
=======

Nox4 is required for a physiological exercise response {#s2-1}
------------------------------------------------------

It was previously shown that Nox4 mRNA and protein levels are low in the adult mouse heart but are upregulated by chronic hemodynamic overload ([@bib42]). We first analysed whether myocardial Nox4 levels change in response to physiological exercise. In mice subjected to 2 bouts of 1500 m moderate intensity treadmill exercise on consecutive days, there was a significant increase in myocardial Nox4 mRNA and protein levels as compared to sedentary mice ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). No change was observed in the expression levels of Nox2, the other main Nox isoform that is expressed in the heart ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}) or in Nox2 activation as assessed by the membrane translocation of its essential regulatory subunit, p47^phox^, after physiological exercise ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). We next conducted a maximal exercise capacity test in which *Nox4*-null mice and matched wild-type littermates were run to exhaustion on day 3. This test revealed that *Nox4*-null mice had a maximal running distance that was \~60% of that in wild-type controls and a maximal running time that was \~65% of that in controls ([Figure 1B](#fig1){ref-type="fig"}). These results indicate that Nox4 has an essential role in facilitating acute exercise in healthy mice.

![Nox4 mediates myocardial Nrf2 activation and is essential in the acute response to exercise.\
(**A**) Changes in myocardial Nox4 mRNA and protein levels after acute moderate exercise (Ex) compared to sedentary controls (Sed). \*p\<0.05, \*\*p\<0.01, 2-tailed t-test (n = 4--6/group). (**B**) Exercise capacity of *Nox4*-null mice (Nox4KO) and littermate wild-types (WT) measured by maximal running distance and running time. \*\*p\<0.01, 2-tailed t-test (n = 5--8/group). (**C**) Ratio of glutathione/glutathione disulfide (GSH/GSSG) in Nox4KO and WT mouse hearts before (Sed) and after exercise (Ex). n = 6--9/group. (**D**) Protein levels of 4-hydroxynonenal (4-HNE) adducts in the heart. n = 3--4/group. (**E and F**) Protein and mRNA levels of major Nrf2 targets. n = 3--6/group \*p\<0.05, \*\*p\<0.01 vs respective sedentary controls (Sed); \#p\<0.05, \#\#p\<0.01 vs WT/Ex, 1-way ANOVA followed by Tukey post hoc analysis. CAT: catalase, GSTA2: glutathione S-transferase A2, GCLC: glutamate cysteine ligase catalytic subunit, TXNRD1: thioredoxin reductase 1.](elife-41044-fig1){#fig1}

Nox4 mediates exercise-induced activation of Nrf2 in the heart {#s2-2}
--------------------------------------------------------------

To investigate potential mechanisms underlying the lower exercise capacity in *Nox4*-null mice, we first assessed exercise-induced changes in myocardial redox state. The ratio of glutathione/glutathione disulfide (GSH/GSSG), a sensitive marker of cellular redox state, was significantly lower after treadmill running in *Nox4*-null compared to sedentary mouse hearts ([Figure 1C](#fig1){ref-type="fig"}). Consistent with a more oxidized cellular environment, the levels of 4-hydroxynonenal (4-HNE) adducts as a marker of lipid peroxidation due to oxidative stress were significantly increased in the myocardium of *Nox4*-null mice after exercise ([Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). These results suggest that the loss of exercise-induced increase in Nox4 levels results in elevated oxidative stress in the heart after acute exercise.

Since Nrf2 is an important regulator of exercise-induced redox adaptations ([@bib7]), we assessed whether the absence of Nox4 affects Nrf2 levels during acute exercise. Myocardial Nrf2 protein levels were significantly elevated after acute exercise in wild-type mice but this response was absent in *Nox4*-null mice ([Figure 1E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In parallel with the rise in Nrf2, wild-type mouse hearts showed increases in transcript levels of the major Nrf2 target genes *Cat*, *Gsta2*, *Gclc* and *Txnrd1* ([Figure 1F](#fig1){ref-type="fig"}), as well as increases at protein level ([Figure 1E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). However, there was no increase in levels of these antioxidant defence proteins after exercise in *Nox4*-null mice ([Figure 1E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). No differences were observed between wild-type and *Nox4*-null mouse hearts at baseline. Therefore, physiological exercise-induced activation of the Nrf2 pathway in the heart appears to be dependent on endogenous Nox4.

Cardiac Nox4 deficiency impairs heart function and exercise capacity due to lack of Nrf2 activation {#s2-3}
---------------------------------------------------------------------------------------------------

To exclude potential systemic effects of global Nox4 deficiency and to specifically establish the functional role of cardiomyocyte Nox4 during exercise, we next studied inducible cardiomyocyte-specific Nox4 knockout (csNox4KO) mice ([@bib45]). csNox4KO mice were compared to Cre-negative Flox control mice. Similar to *Nox4*-null mice, the csNox4KO animals failed to display an increase in Nrf2 target genes upon exercise ([Figure 2A](#fig2){ref-type="fig"}), consistent with a lack of Nrf2 activation. There was no difference between csNox4KO mice and matched control mice in the absence of exercise. The csNox4KO mice achieved a significantly shorter running distance and exercise time than matched controls during an exercise capacity test ([Figure 2B](#fig2){ref-type="fig"}), with the magnitude of defect being very similar to that observed in global *Nox4*-null mice. We assessed cardiac contractile function by echocardiography in conscious mice, immediately upon cessation of the exercise capacity test. While the left ventricular fractional shortening (FS) increased by 24% in the control group at peak exercise, there was a 6% decrease in FS in the csNox4KO group ([Figure 2C](#fig2){ref-type="fig"}). The increase in FS in control animals was driven by a decrease in end-systolic dimension, indicative of increased contractility, which was absent in csNox4KO mice whereas there was no difference in the heart rate response between groups ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}).

![Cardiac Nox4 deficiency impairs heart function and exercise capacity due to lack of Nrf2 activation.\
(**A**) Expression of Nrf2-related genes in hearts of cardiomyocyte-specific Nox4KO (csNox4KO) and littermate controls after exercise (Ex). n = 3--4/group. \*\*p\<0.01 vs respective sedentary controls (Sed); \#p\<0.05, \#\#p\<0.01 vs Control/Ex. (**B**) Maximal exercise distance and time. n = 3--5/group. \*p\<0.05 vs Control/Ex; \#p\<0.05, \#\#p\<0.01 vs csNox4KO/Ex, 1-way ANOVA followed by Tukey post hoc analysis. (**C**) Fractional shortening (FS) evaluated by conscious echocardiography in control and csNox4KO mice immediately after the exercise capacity test. Some animals were treated with sulforaphane (SFN) prior to exercise. n = 4--12/group. \*\*p\<0.01 vs Sed; \#\#p\<0.01 vs Control/Ex, 2-way ANOVA followed by Tukey post hoc analysis. *Cat*: catalase, *Gsta2*: glutathione S-transferase A2, *Gclc*: glutamate cysteine ligase catalytic subunit, *Txnrd1*: thioredoxin reductase 1.](elife-41044-fig2){#fig2}

To assess whether the defect in cardiac performance and exercise capacity in csNox4KO mice is related to the absence of Nrf2 activation, we treated both csNox4KO and control animals with an Nrf2 activator, sulforaphane, administered for 2 days prior to the exercise capacity test. The treatment with sulforaphane fully restored the exercise-induced increase in cardiac performance and maximal exercise capacity in csNox4KO mice (**[Figure 2](#fig2){ref-type="fig"}, B** and **C,** and [Figure 2---figure supplement 1, B](#fig2s1){ref-type="fig"} and **C**). Taken together, these results suggest that cardiomyocyte Nox4-dependent activation of Nrf2 is essential for the normal physiological increase in cardiac performance during acute exercise, which is required to achieve maximal exercise capacity.

Cardiomyocyte Nrf2 is required for optimal increments in heart performance during exercise {#s2-4}
------------------------------------------------------------------------------------------

To more directly define the role of cardiac Nrf2 in the physiological response to exercise, we generated a new mouse line with a cardiomyocyte-specific deletion of Nrf2 (csNrf2KO mice, [Figure](#fig3){ref-type="fig"} [3, A and B](#fig3){ref-type="fig"}). The csNrf2KO mice showed a significant cardiac-specific decrease in *Nrf2* mRNA levels in the heart with no change in other organs ([Figure](#fig3){ref-type="fig"} [3, C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). There was an approximately 60% reduction in Nrf2 protein in the heart ([Figure 3D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), with the residual levels in csNrf2KO mice probably attributable to expression in non-myocytes. There were no differences in baseline cardiac size or function between csNrf2KO mice and control *Nrf2*^fl/fl^ littermates ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Myocardial levels of Nox4 were similar in csNrf2KO mice and control littermates at baseline and increased to a similar extent in both genotypes after acute exercise ([Figure 3E](#fig3){ref-type="fig"}), confirming that Nox4 lies upstream of Nrf2. However, when the two groups were subjected to a maximal exercise capacity test, the csNrf2KO mice exhibited a significant impairment of cardiac function ([Figure 3F](#fig3){ref-type="fig"}) and a reduced running distance and time as compared to control littermates ([Figure](#fig4){ref-type="fig"} [4, D and E](#fig4){ref-type="fig"}). These results indicate a critical role of cardiomyocyte Nrf2 in facilitating an optimal cardiac functional response to acute exercise.

![Cardiomyocyte-targeted *Nrf2* knockout mice have impaired mitochondrial function and reduced heart performance upon exercise.\
(**A**) Targeting strategy for generation of *Nrf2*^fl/fl^ mice (Flox). The endogenous *Nrf2* locus is shown at the top and the targeting vector at the bottom. Exons 2--5 were flanked by LoxP sites which are represented by blue triangles; FRT (Neo) and F3 (Puro) sites are shown by double red triangles. Cre-mediated recombination deletes a 5.5 kb fragment including most of the open-reading frame and the 3^'^UTR. (**B**) Southern blot analysis of genomic DNA from selected ES cell clones, performed after excision at HincII sites, showing correct 3' homologous recombination in all clones. WT indicates wild-type. (**C**) Nrf2 mRNA levels (n = 6/group) and (**D**) protein levels (n = 3/group) in the hearts of csNrf2KO and Flox control mice. \*\*p\<0.01, 2-tailed t-test. (**E**) Increase in *Nox4* mRNA levels in csNrf2KO and control mouse hearts after acute moderate exercise. \*\*p\<0.01 vs respective sedentary controls, 2-tailed t-test (n = 6/group). (**F**) Fractional shortening (FS) by echocardiography immediately after the exercise capacity test. \*p\<0.05 vs sedentary (Sed) Flox control mice, 1-way ANOVA followed by Tukey post hoc analysis (n = 6--7/group). (**G**) Respiration rates in isolated cardiac mitochondria of csNrf2KO and control mice after exercise. Both ADP-limited oxidative phosphorylation (OXPHOS~Lim~) and maximal oxidative capacity (OXPHOS~Max~) were measured (see Materials and methods for details). \*p\<0.05 vs csNrf2KO/Sed, \# p\<0.05 Flox/Ex, 1-way ANOVA followed by Tukey post hoc analysis (n = 4--6/group). (**H**) Citrate synthase (CS) activity in the heart. n = 4--6/group.](elife-41044-fig3){#fig3}

![Cardiomyocyte Nrf2 is required for increase in mitochondrial antioxidant capacity with exercise.\
(**A**) Western blots for peroxiredoxin III (PRXIII), thioredoxin reductase-2 (TRXR2) and superoxide dismutase-2 (SOD2) in heart of csNrf2KO and Flox controls after acute exercise (Ex). Mean data from n = 4--6/group are shown on the right. \*p\<0.05 vs respective sedentary controls (Sed); \#p\<0.05, \#\#p\<0.01 vs Flox/Ex, 1-way ANOVA followed by Tukey post hoc analysis. (**B**) In vivo mitochondrial H~2~O~2~ levels assessed by the MitoP/MitoB ratio in hearts of csNrf2KO mice and controls after acute exercise. \*\*p\<0.01 vs Flox/Sed, 1-way ANOVA followed by Tukey post hoc analysis (n = 5--6/group). (**C**) MitoQ treatment improved cardiac contractile performance at peak exercise in csNrf2KO mice. n = 6--7/group. (**D**) and (**E**) The effect of MitoQ treatment on maximal running distance and time. n = 7--11/group. \*p\<0.05, \*\*p\<0.01 vs Flox/Ex, \#p\<0.05, \#\#p\<0.01 vs csNrf2KO/Ex, 2-way ANOVA followed by Tukey post hoc analysis.](elife-41044-fig4){#fig4}

Mitochondrial function is impaired in csNrf2KO mice after exercise {#s2-5}
------------------------------------------------------------------

We sought to identify mechanisms that account for the beneficial effects of Nrf2 activation on the acute response to exercise. Since optimal mitochondrial function is essential to support an increase in cardiac output during exercise and depends upon a preserved redox state, we investigated mitochondrial respiratory function in csNrf2KO mice and control littermates. Cardiac mitochondria were isolated from csNrf2KO mice and control littermates immediately upon completion of the exercise capacity test and studied by high-resolution respirometry. There were no significant differences between sedentary csNrf2KO mice and littermate controls in respiratory capacity measured as ADP-limited and maximal oxidative phosphorylation (OXPHOS~Lim~ and OXPHOS~Max~, respectively) ([Figure 3G](#fig3){ref-type="fig"}). However, after exercise, both sub-maximal and maximal respiratory capacity were significantly lower in csNrf2KO mice compared to littermate sedentary controls ([Figure 3G](#fig3){ref-type="fig"}). Neither mitochondrial efficiency (P:O ratio) nor respiratory coupling ratio (an index of the tightness of coupling between respiration and phosphorylation) were altered by genotype or exercise ([Figure 3---figure supplement 3A and B](#fig3s3){ref-type="fig"}). Mitochondrial membrane integrity as assessed by the response to cytochrome C in the oxygraph protocol was similar among groups ([Figure 3---figure supplement 3C](#fig3s3){ref-type="fig"}). Mitochondrial mass, as estimated by the total citrate synthase activity, was also similar between genotypes ([Figure 3H](#fig3){ref-type="fig"}). Results from the substrate-uncoupler-inhibitor-titration (SUIT) protocol confirmed impaired mitochondrial oxidative phosphorylation capacity in exercised csNrf2KO hearts when using fatty acids, complex I and complex II substrates ([Figure 3---figure supplement 3D](#fig3s3){ref-type="fig"})

Nox4 and Nrf2 are required for exercise-induced increases in mitochondrial antioxidants {#s2-6}
---------------------------------------------------------------------------------------

In view of the impaired mitochondrial function at peak exercise in csNrf2KO mice, we hypothesised that there may be a defect in the redox homeostasis required for normal respiratory function ([@bib12]). We found that acute exercise resulted in significant increases in the levels of the major mitochondrial antioxidants peroxiredoxin III (PRXIII), thioredoxin reductase-2 (TRXR2) and superoxide dismutase 2 (SOD2) in littermate control mouse hearts ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These increases were, however, abolished in the hearts of exercised csNrf2KO mice although there were no differences between sedentary csNrf2KO and control mice. A similar abolition of exercise-induced increase in these mitochondrial antioxidants was also found in Nox4KO hearts ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). These findings indicate that the Nox4/Nrf2 axis is required for exercise-induced increases in mitochondrial antioxidants.

To investigate the impact of the altered mitochondrial antioxidants in csNrf2KO mouse hearts with exercise, we assessed mitochondrial hydrogen peroxide (H~2~O~2~) levels in vivo using injection of the mitochondrial-targeted probe MitoB ([@bib3]). This probe is rapidly concentrated in mitochondria where it reacts with H~2~O~2~ to form MitoP; quantification of the MitoP/MitoB ratio by LC-MS provides a sensitive measure of mitochondrial H~2~O~2~ levels ([@bib15]). We found in normal mouse hearts that mitochondrial H~2~O~2~ levels were significantly lower immediately upon cessation of peak exercise than in the non-exercising state ([Figure 4B](#fig4){ref-type="fig"}) -- consistent with a reduction in ROS at peak exercise due to an enhanced antioxidant state. In marked contrast, there was no decrease in mitochondrial H~2~O~2~ levels with exercise in csNrf2KO mice, in line with the failure to enhance mitochondrial antioxidants. There were no significant differences between genotypes in sedentary mice.

Supplementation with a mitochondria-targeted antioxidant rescues the physiological cardiac response and exercise capacity in csNrf2KO mice {#s2-7}
------------------------------------------------------------------------------------------------------------------------------------------

Finally, to confirm that the defect in mitochondrial redox balance is responsible for the impaired cardiac performance and exercise capacity in csNrf2KO mice, we performed rescue experiments in which mice were treated with a small molecule mitochondria-targeted antioxidant, MitoQ, for 2 days prior to the exercise capacity test ([@bib38]). We found that MitoQ supplementation markedly improved cardiac performance at peak exercise in csNrf2KO mice and fully restored the maximal exercise capacity in these animals ([Figure](#fig4){ref-type="fig"} [4, C to E](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). MitoQ did not have a significant additional effect on exercise performance in control mice.

Discussion {#s3}
==========

The multiple beneficial effects of regular exercise depend upon the ability of the healthy heart to safely and consistently increase its contractile performance during the periods when cardiac output and overall body oxygen consumption are elevated. It has long been recognized that adaptations that facilitate the heart's ability to safely undertake repetitive exercise begin to be triggered very rapidly, after just 1--3 episodes of consecutive exercise. One of the most important of such adaptations may be the maintenance of a physiological redox balance, given that this is crucial for mitochondrial energy metabolism and heart contractile performance ([@bib26]). In this study, we identify cardiomyocyte Nox4 as the physiological driver of exercise-induced upregulation of endogenous antioxidants, serving to preserve mitochondrial redox state and respiratory function and thereby facilitate optimal cardiac contractile performance and exercise capacity ([Figure 5](#fig5){ref-type="fig"}). We show that consecutive episodes of exercise upregulate myocardial Nox4 levels and lead to the activation of an Nrf2-dependent transcriptional program that boosts endogenous antioxidants and mitigates oxidative stress during exercise. The cardiomyocyte-specific loss of either Nox4 or Nrf2 results in a significant reduction in exercise cardiac performance and maximal exercise capacity in healthy adult mice. The exercise defect in cardiomyocyte-specific *Nox4*-deficient mice is corrected by a small molecule Nrf2 activator, sulforaphane, placing Nrf2 activation downstream of Nox4. On the other hand, the defect in exercise capacity in cardiomyocyte-specific *Nrf2*-deficient mice can be rescued by a mitochondria-targeted antioxidant, MitoQ, confirming that it relates to a disruption of mitochondrial redox balance. Taken together, these data identify a crucial Nox4-dependent physiological pathway that mediates cardiac adaptation to repeated acute exercise.

![Schematic illustrating the role of the cardiomyocyte Nox4-Nrf2 pathway in enhancing mitochondrial and cardiac contractile function during acute physiological exercise.\
Cardiac Nox4 levels increase in response to acute exercise and induce an activation of Nrf2. The Nrf2-dependent gene program includes endogenous antioxidants that are critical in maintaining mitochondrial redox balance during peak exercise. The maintenance of mitochondrial redox balance is essential to achieve maximal mitochondrial respiration and cardiac contractile function at peak exercise. The sites of action of the Nrf2 activator sulforaphane and the mitochondria-targeted antioxidant MitoQ are shown.](elife-41044-fig5){#fig5}

The activity of Nox4 depends on its protein abundance but its levels in the healthy adult heart are very low ([@bib2]). Previous studies show that an increase in Nox4 abundance is induced by diverse pathological stresses such as hypoxia, ischaemia and haemodynamic overload ([@bib42]). In the current study, cardiac Nox4 mRNA and protein levels were significantly increased after two bouts of moderate intensity exercise on consecutive days. The precise stimulus for the increase in Nox4 levels with exercise was not studied. However, the transcriptional induction of Nox4 by ATF4 was recently identified as an important mechanism for its stress-induced upregulation ([@bib32]), and it is of interest that exercise is reported to upregulate ATF4 in human skeletal muscle ([@bib8]). An increase in levels of Nox4 as a ROS-producing protein complex might be envisaged to generate detrimental oxidative stress. However, it has been found that Nox4 mediates protective effects in pathological stress situations, such as chronic hemodynamic overload or nutrient starvation in the heart ([@bib42]; [@bib35]) and angiotensin II-induced remodelling or atherosclerosis in the vasculature ([@bib4]; [@bib33]; [@bib34]). These effects typically involve localized redox signalling without overt oxidative stress. In fact, Nox4 was found to specifically activate Nrf2 during load-induced cardiac remodeling ([@bib39]) and during angiotensin II-induced vascular remodeling ([@bib33]). Here, we show that myocardial Nox4 mediates a similar activation of Nrf2 during acute exercise -- representing to the best of our knowledge the first physiological function of cardiac Nox4 that has so far been identified. The Nox4-dependent activation of Nrf2 was required for optimal cardiac function and running capacity during maximal exercise, as evidenced by the restoration of normal exercise responses in *Nox4*-deficient animals that were treated with the Nrf2 activator, sulforaphane. Notably, we observed no increase in cardiac contractility as assessed by fractional shortening in *Nox4*-deficient mice at peak exercise whereas there was a 24% increase in wild-type animals.

Nrf2 is a master transcriptional regulator of antioxidant and stress-defense proteins and previous studies found that it is activated in the heart upon acute exercise ([@bib20]). A canonical mechanism for Nrf2 activation is in response to redox signals which result in its post-translational stabilisation. In principle, Nrf2 activation could be activated by diverse sources of ROS, such as mitochondria or different Nox isoforms. However, here we find that endogenous Nox4 is an essential and indispensable regulator of myocardial Nrf2 activation during physiological acute exercise. As such, the acute increase in myocardial Nrf2 protein levels and its major downstream targets (such as antioxidants and GSH-generating enzymes) was markedly inhibited in the hearts of *Nox4*-null mice or csNox4KO mice. Furthermore, this was accompanied by a significant redox imbalance as assessed by the GSH/GSSG ratio and by evidence of oxidative stress as assessed by the levels of 4-HNE adducts, along with a reduced maximal exercise capacity. Therefore, the absence of Nox4 resulted in redox imbalance during exercise as a result of impaired Nrf2 activation and impaired antioxidant reserve, and led to a significant impairment of exercise performance. The increased ROS levels in this setting most likely emanated from mitochondria ([@bib27]; [@bib30]), as evidenced by experiments using the mitochondria-targeted redox probe MitoB and the mitochondrial-targeted antioxidant MitoQ.

To more specifically establish the role of cardiomyocyte Nrf2 in exercise-induced cardiac adaptation and determine how it enhances exercise performance, we developed a new mouse model with cardiomyocyte-specific deficiency of Nrf2. These animals had a normal heart structure and function at baseline but displayed a significant impairment of cardiac performance and running capacity upon maximal exercise, similar to the phenotype observed in *Nox4*-deficient animals. The csNrf2KO mice, however, developed a similar elevation in cardiac Nox4 levels upon exercise to that observed in control mice, consistent with Nox4 being upstream of Nrf2. Investigation of cardiac mitochondrial function in csNrf2KO mice revealed that the respiratory capacity at maximal exercise was significantly impaired compared to control animals, without any differences in mitochondrial mass or membrane integrity. Although emerging data suggest that Nrf2 can have multi-faceted effects on mitochondrial metabolism ([@bib6]; [@bib12]; [@bib19]), we found no difference in cardiac mitochondrial function between sedentary csNrf2KO and control mice, indicating that the difference between genotypes was specific to exercise. Further analyses revealed that the csNrf2KO mouse hearts failed to increase the mitochondrial antioxidants PRXIII, TRXR2 and SOD2 upon exercise, in contrast to control animals. In parallel, we found that mitochondrial ROS levels were lower after exercise in control mice (consistent with increased antioxidant levels) but that this response was absent in csNrf2KO mouse hearts. Taken together, these results indicate that an Nrf2-dependent induction of mitochondrial antioxidants is critical to maintain redox balance during acute exercise. Our study also shows that cardiomyocyte Nox4 is the essential activator of this adaptive response, resulting in the maintenance of optimal mitochondrial respiration and cardiac function during maximal exercise ([Figure 5](#fig5){ref-type="fig"}).

Whether antioxidant supplementation improves exercise performance is a controversial question ([@bib18]; [@bib29]). A reduction in excessive oxidative stress resulting from mitochondrial ROS production is likely to be beneficial but if ROS-mediated adaptive responses are inhibited by antioxidants, this might be detrimental ([@bib14]; [@bib31]). Previous studies have identified several ROS-mediated adaptive responses during exercise. The current study suggests that what is ultimately most important is the redox balance during exercise, especially at the level of the mitochondria. Targeted antioxidants such as MitoQ that primarily reduce mitochondrial ROS levels ([@bib24]) may be more likely to have beneficial effects than non-specific antioxidants that might inhibit Nrf2 activation. Interestingly, we did not find any beneficial effects of either sulforaphane or MitoQ in the control animal groups, suggesting that there is limited scope for further enhancement of the adaptive exercise redox response in healthy adult mice with normal Nox4/Nrf2 activation, at least in the relatively acute setting. This is consistent with prior findings that MitoQ did not enhance aerobic training adaptations or skeletal muscle oxidative capacity in young healthy men ([@bib37]). However, it is possible that the Nox4/Nrf2/mitochondrial antioxidant pathway could be usefully augmented in older individuals or those with disease-related impairment of this response.

Taken together, these data identify cardiomyocyte Nox4 as a crucial physiological mediator of Nrf2 activation, triggering an adaptive response that maintains redox state, mitochondrial function and cardiac contractile performance to support normal physical exercise.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\     Designation               Source or\                  Identifiers                                                              Additional information
  (species) or\                               reference                                                                                            
  resource                                                                                                                                         
  ----------------- ------------------------- --------------------------- ------------------------------------------------------------------------ -----------------------------------
  Genetic\          *Nox4*-null               PMID: 20921387                                                                                       Dr. Schröder (Institut für\
  reagent\                                                                                                                                         Kardiovaskuläre Physiologien,\
  (*M. musculus*)                                                                                                                                  Goethe-Universität)

  Genetic\          cardiomyocyte-specific\   PMID: 29040462                                                                                       Dr. Shah (King\'s College London\
  reagent\          Nox4 knockout                                                                                                                  British Heart Foundation\
  (*M. musculus*)                                                                                                                                  Centre of Excellence)

  Genetic\          *Nrf2*^fl/fl^             in this paper                                                                                        Dr. Shah (King\'s College London\
  reagent\                                                                                                                                         British Heart Foundation\
  (*M. musculus*)                                                                                                                                  Centre of Excellence)

  Genetic\          Myl2^tm1(cre)Krc^         The Jackson\                RRID:[IMSR_JAX:029465](https://scicrunch.org/resolver/IMSR_JAX:029465)   
  reagent\                                    Laboratory\                                                                                          
  (*M. musculus*)                             (Stock No: 029465)                                                                                   

  Antibody          Anti-GSTA2\               Sigma-Aldrich\              RRID:[AB_10609834](https://scicrunch.org/resolver/AB_10609834)           
                    (rabbit polyclonal)       Cat\# SAB1401163                                                                                     

  Antibody          Mouse Anti-GAPDH\         Sigma-Aldrich\              RRID:[AB_1078991](https://scicrunch.org/resolver/AB_1078991)             
                    Monoclonal Antibody       Cat\# G8795                                                                                          

  Antibody          Anti-4 Hydroxynonenal\    Abcam Cat\# ab46545         RRID:[AB_722490](https://scicrunch.org/resolver/AB_722490)               
                    Rabbit Polyclonal\                                                                                                             
                    Antibody                                                                                                                       

  Antibody          Anti-MnSOD Rabbit\        Abcam Cat\# ab13533         RRID:[AB_300434](https://scicrunch.org/resolver/AB_300434)               
                    Polyclonal Antibody                                                                                                            

  Antibody          Anti-GCLC Rabbit\         Novus Cat\# NBP1-49762      RRID:[AB_10011848](https://scicrunch.org/resolver/AB_10011848)           
                    Polyclonal Antibody                                                                                                            

  Antibody          Anti-Catalase Rabbit\     Millipore Cat\#219010       RRID:[AB_211660](https://scicrunch.org/resolver/AB_211660)               
                    Polyclonal Antibody                                                                                                            

  Antibody          TrxR2 Goat\               Santa Cruz Biotechnology\   RRID:[AB_2210408](https://scicrunch.org/resolver/AB_2210408)             
                    Polyclonal Antibody       Cat\# sc-46278                                                                                       

  Antibody          PRX III (C-14) Goat\      Santa Cruz Biotechnology\   RRID:[AB_2237431](https://scicrunch.org/resolver/AB_2237431)             
                    Polyclonal Antibody       Cat\# sc-23973                                                                                       

  Antibody          NFE2L2-Rabbit\            Santa Cruz Biotechnology\   RRID:[AB_2263168](https://scicrunch.org/resolver/AB_2263168)             
                    Polyclonal Antibody       Cat\# sc-13032                                                                                       

  Antibody          NFE2L2-Rabbit\            Santa Cruz Biotechnology\   RRID:[AB_2108502](https://scicrunch.org/resolver/AB_2108502)             
                    Polyclonal Antibody       Cat\# sc-722,                                                                                        

  Antibody          VE-cadherin (F-8)\        Santa Cruz Biotechnology\   RRID:[AB_2077957](https://scicrunch.org/resolver/AB_2077957)             
                    monoclonal antibody       Cat\# sc-9989                                                                                        

  Antibody          Anti-p47-phox (mouse)\    Millipore Cat\# 07--500     RRID:[AB_310668](https://scicrunch.org/resolver/AB_310668)               
                    antibody                                                                                                                       

  Antibody          gp91phox mouse\           BD Biosciences\             RRID:[AB_398936](https://scicrunch.org/resolver/AB_398936)               
                    monoclonal antibody       Cat\# 611414                                                                                         

  Antibody          Nox4 rabbit polyclonal\   PMID: 18467643                                                                                       [@bib1]
                    antibody                                                                                                                       
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

The studies complied with the UK Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 and King's College London institutional guidelines. All the mouse lines studied were on a C57BL/6 background. Global Nox4KO mice were described previously ([@bib42]) and were compared to littermate wild-type controls. Inducible cardiomyocyte-specific Nox4KO mice (csNox4KO) were generated by crossing *Nox4*^fl/fl^ female mice with male α-MHC-MerCreMer mice ([@bib45]). Tamoxifen was administered by i.p. injection (20 mg/kg/day) for 5 days to induce Cre expression. csNox4KO mice were compared with tamoxifen-treated Cre-negative Flox littermates, with the groups subjected to the exercise regime 1 week after completion of tamoxifen treatment. Tamoxifen treatment itself had no effect on cardiac function (data not shown).

The generation of *Nrf2*^fl/fl^ mice was commissioned from Taconic-Artemis (Germany). In brief, the targeting vector was generated using BAC clones from the C57BL/6 RPCI-23 BAC library. The LoxP sites flanked exons 2 and 5 and the vector included an FRT (neomycin resistance) and F3 (puromycin resistance) site. The targeting vector was transfected into C57BL/6 Tac embryonic stem (ES) cell lines and recombinant clones were identified by PCR and Southern blotting, then injected into blastocysts. Heterozygous Floxed mice obtained from germline chimeras were bred with C57BL/6 Flp-deletor mice to excise the resistance cassettes. Mice were backcrossed onto a C57BL/6 background. Cardiomyocyte-specific *Nrf2* knock-out mice (designated as csNrf2KO) were obtained by crossing *Nrf2*^fl/fl^ mice with Cre-recombinase expressing mice under the control of a cardiomyocyte-specific Mlc2v promoter (Mlc2vCre). csNrf2KO and littermate *Nrf2*^fl/fl^ controls were obtained by intercrossing Mlc2vCre^+/-^/*Nrf2*^fl/fl^ mice with *Nrf2*^fl/fl^ mice.

Acute exercise regimes {#s4-2}
----------------------

We studied female *Nox4*-null mice, csNox4KO mice or csNrf2KO mice and their respective littermate controls. Mice of age approximately 8 weeks were acclimatized to and trained on a 12.5° uphill Exer 3/6 open treadmill (Columbus Instruments) for 2 days. On both training days, mice ran for a total of 10 min, with a continual increase in speed up to a final speed of 15 m/min. Mice were then randomly assigned into a sedentary or exercise group. The exercise regime used in the study is a moderate intensity protocol as reported previously ([@bib9]; [@bib20]). Briefly, on day 3 and 4 (experimental days 1 and 2), mice in the exercise group were subjected to a single bout of running at 15 m/min at a gradient of 12.5° for a total of 1500 m. Tissues for analyses of gene expression or immunoblotting were obtained after the second prolonged period of exercise.

Exercise capacity tests were performed on day 5 (experimental day 3). Mice started running at an initial treadmill speed of 15 m/min for 30 min. The speed was then increased at 1 m/min every 10 min for another 30 min, followed by a 1 m/min increase every 5 min until the mice were exhausted. Exhaustion was defined as the point at which mice spent more than 5 s on the electric shocker without attempting to resume running. The total running distance and running time were calculated for each mouse ([@bib11]). In some experiments, sulforaphane (0.5 mg/kg i.p.) or MitoQ (4 mg/kg i.p.) were administered 24 hr and 2 hr prior to each exercise regime, respectively.

Echocardiography {#s4-3}
----------------

Immediately upon discontinuation of the exercise capacity test, cardiac function was evaluated in conscious mice by transthoracic echocardiography using a Vevo2100 system (Visualsonics, Canada) ([@bib44]). Echocardiography was undertaken on the same mouse prior to exercise as a baseline. Echocardiography was performed by an experienced operator blinded to the assignments. Images were acquired using M-mode at a depth setting of 11 mm and analyzed using Vevo software v1.7. Mice were acclimatized to conscious echocardiography over 2--3 days. Basal cardiac structure and function in sedentary csNrf2KO mice was assessed by echocardiography under 2% isoflurane anesthesia at heart rates \> 400 bpm ([@bib44]).

Real-time PCR {#s4-4}
-------------

mRNA expression levels were quantified by real-time RT-PCR using SYBR Green on an Applied Biosystem PRISM 7700 machine. Delta delta Ct values were calculated with hypoxanthine-guanine phosphoribosyltransferase (HPRT) as an internal control. Primer sequences were (forward, reverse):

*Nfe2l2*, Nuclear factor, erythroid 2 like 2 (or Nrf2): CTACTCCCAGGTTGCCCACA, CGACTCATGGTCATCTACAAATGG;

*Nox4*, NADPH oxidase-4: CCGGACAGTCCTGGCTTATC, TGCTTTTATCCAACAATCTTCTTTT;

*Cat*, Catalase: CCCTTCGCAGCCATGTG, GCTGAGAAGCCTAAGAACGCAAT;

*Gsta2*, Glutathione S-transferase, alpha 2 (Yc2): GCTTGATGCCAGCCTTCTG, GGCTGCTGATTCTGCTCTTGA;

*Gclc*, Glutamate-cysteine ligase, catalytic subunit: GTTATGGCTTTGAGTGCTGCAT, ATCACTCCCCAGCGACAATC;

*Txnrd1,* thioredoxin reductase 1: GATGCACCAGGCAGCTTTG; TCTTCGACTTTCCAGCCATAGT;

*Hprt*, Hypoxanthine guanine phosphoribosyl transferase: CACAGGACTAGAACACCTGC, GCTGGTGAAAAGGACCTCT;

Western blotting {#s4-5}
----------------

Snap-frozen heart tissues were homogenized for immunoblotting. Antibodies used were: Nrf2, thioredoxin reductase-2, peroxiredoxin III and cadherin (Santa Cruz); Nox4 ([@bib1]); Nox2 (BD Biosciences); p47^phox^, catalase (Millipore); glutathione S-transferase A2, 4-hydroxynonenal, superoxide dismutase-2 (Abcam); glutamate-cysteine ligase catalytic subunit (Novus biologicals). GAPDH (Sigma) was used as a loading control. Protein bands were visualized using enhanced chemiluminescence or fluorescence (Odyssey, LI-COR), and were quantified by densitometry.

Membrane proteins were obtained from heart homogenates using a standard centrifugation protocol ([@bib16]). Cadherin and GAPDH were used as protein markers for the membrane and cytosolic fractions, respectively.

Glutathione assay {#s4-6}
-----------------

The ratio of glutathione/glutathione disulfide (GSH/GSSG) in left ventricular homogenates was evaluated using a GSH-Glo assay kit (Promega) ([@bib2]), as a global measure of antioxidant status in the heart.

Estimation of mitochondrial H~2~O~2~in vivo {#s4-7}
-------------------------------------------

The mitochondrial-targeted probe, MitoB, was used to assess mitochondrial H~2~O~2~ levels in vivo, as previously described ([@bib3]; [@bib15]). MitoB can also react with peroxynitrite, but this reactive nitrogen species was not thought to contribute to the changes seen here. Briefly, 25 nmol MitoB in 50 µL saline was administered by tail vein injection 2 hr before the exercise capacity test on experimental day 3. Hearts were excised immediately upon completion of exercise, snap frozen in liquid nitrogen and stored at −80°C. For analysis, around 50 mg tissue was homogenized and spiked with deuterated internal standards. MitoB and MitoP (produced by the reaction with H~2~O~2~) were extracted and quantified by liquid chromatography-tandem mass spectrometry relative to a standard curve ([@bib3]; [@bib15]).

Mitochondrial respiratory function {#s4-8}
----------------------------------

Cardiac mitochondria were isolated immediately upon completion of the exercise capacity test and respiratory function was measured in an oxygraph (Oxygraph 2 k; Oroboros Instruments, Austria) as described previously ([@bib10]; [@bib21]). Briefly, proton leak (Leak) respiration was measured with pyruvate (5 mM) and malate (1 mM) as substrates. ADP-limited respiration (oxidative phosphorylation, OXPHOS~Lim~) was measured in the presence of ADP, 50 µM. Maximal mitochondrial respiratory capacity (OXPHOS~Max~) was measured following the addition of ADP, 500 mM. Cytochrome C (10 µM) was added to assess mitochondrial membrane integrity (OXPHOS~Cyt~). All respiration rates were normalized by the protein content. The phosphate/oxygen ratio (P/O ratio) was calculated from the ratio of molecules phosphorylated to each oxygen molecule consumed. Respiratory coupling ratio (RCR) was calculated as OXPHOS~Max~/Leak.

In order to further study the mitochondrial function, a substrate-uncoupler-inhibitor-titration (SUIT) protocol was performed. Proton leak (Leak~FA~) was measured in the presence of malate (0.5 mM), carnitine (5 mM) and palmityol-CoA (24 µM). Maximal respiratory capacity (oxidative phosphorylation, OXPHOS) was measured following the addition of a saturating amount of ADP (500 mM, OXPHOS~FA~), saturating amounts of the complex I substrates pyruvate (10 mM) and glutamate (10 mM, OXPHOS~FA+CI~) and the complex II substrate succinate (10 mM, OXPHOS~FA+CI+CII~). Maximal electron transport capacity (ETC) was measured following the addition of 0.75 µM carbonyl cyanide *m*-chlorophenyl hydrazone (CCCP) (ETC~FA+CI+CII~). Rotenone (0.5 µM) was used to inhibit complex I (ETC~CII~) and complex II and III were inhibited by malonic acid (5 mM) and antimycin (2.5 µM), respectively (Residual oxygen consumption, ROX). The absolute ROX value was subtracted from the values of measured respiration.

Statistics {#s4-9}
----------

Data are presented as mean ± SEM. Comparisons were made by unpaired t-test, 1-way or 2-way ANOVA as appropriate, followed by Tukey post hoc analysis. p\<0.05 was considered significant.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Myocardial NADPH oxidase-4 regulates the physiological response to acute exercise\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Milica Radisic as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Mark McCarthy as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Kathy Griendling (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers found that your work was novel and thorough.

Essential revisions:

1\) Please comment on the severity of exercise studied.

2\) Studies of mitochondrial respiratory capacity were undertaken on cardiac mitochondria isolated after exercise. Due to the time required for isolation, do the changes reported merely reflect damaged mitochondria?

3\) Please consider an important comment by reviewer 3: \"A lack of change in cardiac Nox2 content (Figure 1---figure supplement 1) is cited as evidence for a lack of involvement of this protein in exercise responses, but Nox2 activity is regulated (differently to Nox4) by assembly and activation of the NADPH oxidase complex rather than protein content. Can this protein therefore be excluded on the basis of Nox2 content? \"

*Reviewer \#1:*

Hancock et al. present a thorough study, performed in a murine model, to support an important role of Nox4 and Nrf2 in cardioprotection during exercise. This paper is specifically focused on delineating mechanisms that lead to the protective (and non-damaging) effects of exercise to the heart. Specifically, oxidative stress is increased during exercise, due to the higher metabolic requirements. This creates ROS overload that the heart is capable of managing. This paper demonstrates through the use of mostly Western blotting and functional measurements in transgenic animals that Nox4 regulated exercise performance by activating Nrf2, which in turn activates mitochondrial antioxidants. Overall, I find this study to be thorough and I have several questions that could further improve the work:

1\) It would be useful to compare mitochondria density and structure in WT and csNrf2KO by TEM to rule out the possibility of other mitochondrial defects.

2\) Figure 2---figure supplement 1, shows rather small differences in cardiac function at peak exercise. Although this might show up as significant in a statistical test, I wonder if it is of any biological relevance.

3\) It would be good to see the entire Western blots in the supplement. Lanes are good in the main text.

Reviewer \#2:

In this manuscript, the authors convincingly demonstrate that cardiac Nox4 mediates the cardiac response to exercise. Up until now, the role of Nox4 in the heart has been probed only in pathological conditions; this is the first study to show a physiological role for Nox4 in the heart, as the authors correctly point out. The study is state-of-the-art, especially with respect to the animal models and the fact that mechanism was investigated in vivo. In general, the data support the conclusions; however, a better characterization of the new csNrf2KO mice is needed before they can truly claim cardiomyocyte specificity.

Major concerns:

1\) Why do the csNrf2KO look like heterozygotes? Both RNA and protein are only reduced by 50%? If this is because samples were taken from whole heart and include non-cardiomyocytes, please be specific. In addition, some confirmation that Nrf levels are not affected in other tissues is necessary before you conclude cardiomyocyte specificity.

2\) The only unconvincing data are those shown in Figure 4B. While it is clear that exercise induces a decrease in H~2~O~2~ production, the slight decrease in baseline in csNrf2KO and the reported levels after exercise do not appear to be different from exercise in WT mice. So perhaps H~2~O~2~ levels are already low in csNrf2KO mice and exercise doesn\'t reduce them further. Please either provide statistics showing that these values are in fact different from WT-exercise or soften this conclusion.

Reviewer \#3:

This paper provides data indicating that cardiac NADPH oxidase-4 (Nox4) is an essential regulator of exercise performance in mice. The authors provide evidence that myocardial Nox4 levels increase during acute exercise and trigger activation of the transcription factor Nrf2, with the induction of multiple endogenous antioxidants. Furthermore cardiomyocyte-specific Nox4-deficient (csNox4KO) mice or Nrf2-deficient (csNrf2KO) mice exhibit similar compromised exercise capacity with mitochondrial and cardiac dysfunction. They hypothesise that Nox4/Nrf2 axis therefore drive a hormetic response that is required for optimal cardiac mitochondrial and contractile function during physiological exercise. While the data are generally compelling there are number of issues with the paper:

1\) Severity of exercise studied. The relevance of the data to physiological responses is dependent upon the nature of the exercise protocol for mice, which the authors describe as acute, moderate aerobic exercise. It is difficult to know how this description is justified. For habitually sedentary caged mice, the protocol described appears to be a severely incremental exercise regimen. Some consideration of this is required.

2\) Studies of mitochondrial respiratory capacity were undertaken on cardiac mitochondria isolated after exercise. Due to the time required for isolation, what is the relevance of such measurements to the state of the mitochondria during exercise -- do the changes reported merely reflect damaged mitochondria?

3\) The authors hypothesise that increased Nox4 activity during exercise stimulates Nrf2 activation, but does the lack of any effect of MitoQ supplementation (a mitochondrial antioxidant) on the responses of control mice argue against this? Do the authors think this is related to the specificity of the action of MitoQ, or to different sub-cellular localisation of the Nox4 and MitoQ, or some other explanation?

4\) A lack of change in cardiac Nox2 content (Figure 1---figure supplement 1) is cited as evidence for a lack of involvement of this protein in exercise responses, but Nox2 activity is regulated (differently to Nox4) by assembly and activation of the NADPH oxidase complex rather than protein content. Can this protein therefore be excluded on the basis of Nox2 content?

10.7554/eLife.41044.020

Author response

> Essential revisions:
>
> 1\) Please comment on the severity of exercise studied.

The exercise regime that we used in this study is a moderate intensity exercise protocol, as reported previously (e.g. Kemi et al., J Appl Physiol 2002, Hafstad et al., 2011, Muthusamy et al., 2012). The co-author Anne Dr Hafstad and colleagues have extensive experience of exercise-intensity controlled protocols in mice on a C57Bl6 background (e.g. Hafstad et al., 2013; Hafstad et al., 2011). High intensity exercise protocols in C57Bl6 mice are typically conducted at a higher inclination (25%) and higher running speeds, and the mice can only sustain high intensity running for a few minutes. Continuous running for \~100min (\> 1500m) is only possible with moderate intensity protocols. We have now clarified that this was a moderate intensity protocol in the Materials and methods (subsection "Acute exercise regimes"), Results (paragraph one) and Figure legends.

> 2\) Studies of mitochondrial respiratory capacity were undertaken on cardiac mitochondria isolated after exercise. Due to the time required for isolation, do the changes reported merely reflect damaged mitochondria?

Mitochondrial preparations were isolated using the same methodology in all groups (KO and controls) and we allowed a 40 min rest period before experiments, so the differences are unlikely to be related to the isolation protocol or time. There were no differences among groups in the mitochondrial yield (protein concentration) and we know from previous work in the lab that respiratory function is stable for at least 2-3 hours after isolation (Hafstad et al., 2011). Furthermore, we formally tested for mitochondrial membrane integrity by examining the response to cytochrome C -- which showed no significant differences among groups. These data are now shown in Figure 3---figure supplement 3 and referred to in the Results (subsection "Mitochondrial function is impaired in csNrf2KO mice after exercise").

> 3\) Please consider an important comment by reviewer 3: \"A lack of change in cardiac Nox2 content (Figure 1---figure supplement 1) is cited as evidence for a lack of involvement of this protein in exercise responses, but Nox2 activity is regulated (differently to Nox4) by assembly and activation of the NADPH oxidase complex rather than protein content. Can this protein therefore be excluded on the basis of Nox2 content?\"

We fully agree with the reviewer's comment that Nox2 activation requires assembly of the oxidase complex and cannot therefore be inferred merely from Nox2 levels. We have now performed additional experiments in which we quantified the protein levels of the essential subunit p47^phox^ in the membrane fraction. Translocation of p47^phox^ to the membrane is a key step in Nox2 activation and is therefore a good surrogate for complex assembly and oxidase activation. The results showed no differences in membrane levels of p47^phox^ with exercise, indicating that there was no significant activation of Nox2. These new results are now included in Figure 1---figure supplement 2B and described in the Results (paragraph 1).

> Reviewer \#1:
>
> Hancock et al. present a thorough study, performed in a murine model, to support an important role of Nox4 and Nrf2 in cardioprotection during exercise. This paper is specifically focused on delineating mechanisms that lead to the protective (and non-damaging) effects of exercise to the heart. Specifically, oxidative stress is increased during exercise, due to the higher metabolic requirements. This creates ROS overload that the heart is capable of managing. This paper demonstrates through the use of mostly Western blotting and functional measurements in transgenic animals that Nox4 regulated exercise performance by activating Nrf2, which in turn activates mitochondrial antioxidants. Overall, I find this study to be thorough and I have several questions that could further improve the work:
>
> 1\) It would be useful to compare mitochondria density and structure in WT and csNrf2KO by TEM to rule out the possibility of other mitochondrial defects.

Guided by the editorial summary, we have not pursued this experiment in the current paper. However, please note that we now show data from experiments with cytochrome C addition to assess mitochondrial membrane integrity (Figure 3---figure supplement 3), which suggest that mitochondrial integrity is preserved.

> 2\) Figure 2---figure supplement 1, shows rather small differences in cardiac function at peak exercise. Although this might show up as significant in a statistical test, I wonder if it is of any biological relevance.

We believe that the differences are indeed physiologically relevant. In awake echocardiography, we found a 24% increase in LV fractional shortening (FS) in the control group at peak exercise whereas csNox4KO mice actually showed a 6% decrease (Figure 2C). Given the high heart rates (\>600 beats/min), this translates into a substantial change in cardiac output. The physiological relevance of this difference in cardiac function in cardiac-specific KO mice is also evident in the marked differences in exercise duration (our intervention in this experiment is cardiac-specific). We have now emphasised the significant differences in cardiac fractional shortening response in the Discussion (paragraph two).

> 3\) It would be good to see the entire Western blots in the supplement. Lanes are good in the main text.

We have provided full images of all Western blots in Supplementary figures.

> Reviewer \#2:

*In this manuscript, the authors convincingly demonstrate that cardiac Nox4 mediates the cardiac response to exercise. Up until now, the role of Nox4 in the heart has been probed only in pathological conditions; this is the first study to show a physiological role for Nox4 in the heart, as the authors correctly point out. The study is state-of-the-art, especially with respect to the animal models and the fact that mechanism was investigated* in vivo*. In general, the data support the conclusions; however, a better characterization of the new csNrf2KO mice is needed before they can truly claim cardiomyocyte specificity.*

> Major concerns:
>
> 1\) Why do the csNrf2KO look like heterozygotes? Both RNA and protein are only reduced by 50%? If this is because samples were taken from whole heart and include non-cardiomyocytes, please be specific. In addition, some confirmation that Nrf levels are not affected in other tissues is necessary before you conclude cardiomyocyte specificity.

As suggested by the reviewer, the mRNA and protein levels were in whole heart and the residual presence of Nrf2 is likely to mainly reflect expression in non-myocytes. We have now specifically commented on this point (subsection "Cardiomyocyte Nrf2 is required for optimal increments in heart performance during exercise"). We also checked Nrf2 mRNA levels in other organs to confirm cardiac-specific expression and now show these results in Figure 3---figure supplement 1.

> 2\) The only unconvincing data are those shown in Figure 4B. While it is clear that exercise induces a decrease in H~2~O~2~ production, the slight decrease in baseline in csNrf2KO and the reported levels after exercise do not appear to be different from exercise in WT mice. So perhaps H~2~O~2~ levels are already low in csNrf2KO mice and exercise doesn\'t reduce them further. Please either provide statistics showing that these values are in fact different from WT-exercise or soften this conclusion.

The reviewer is correct that exercise induces a decrease in H~2~O~2~ levels in control mice whereas no such decrease occurs in csNrf2KO mice -- consistent with the increase in endogenous antioxidants in control mice but no change in the KO mice. Indeed, the main point that we wished to highlight here was the different response to exercise rather than the absolute levels in each group. We have now re-phrased this sentence to make this clearer:

"We found in normal mouse hearts that mitochondrial H~2~O~2~ levels were significantly lower immediately upon cessation of peak exercise than in the non-exercising state (Figure 4B) -- consistent with a reduction in ROS at peak exercise due to an enhanced antioxidant state. In marked contrast, there was no decrease in mitochondrial H~2~O~2~ levels with exercise in csNrf2KO mice, in line with the failure to enhance mitochondrial antioxidants."

> Reviewer \#3:
>
> \[...\] 1) Severity of exercise studied. The relevance of the data to physiological responses is dependent upon the nature of the exercise protocol for mice, which the authors describe as acute, moderate aerobic exercise. It is difficult to know how this description is justified. For habitually sedentary caged mice, the protocol described appears to be a severely incremental exercise regimen. Some consideration of this is required.

Please see the response in Essential Revision above.

> 2\) Studies of mitochondrial respiratory capacity were undertaken on cardiac mitochondria isolated after exercise. Due to the time required for isolation, what is the relevance of such measurements to the state of the mitochondria during exercise -- do the changes reported merely reflect damaged mitochondria?

Please see the response in Essential Revision above.

> 3\) The authors hypothesise that increased Nox4 activity during exercise stimulates Nrf2 activation, but does the lack of any effect of MitoQ supplementation (a mitochondrial antioxidant) on the responses of control mice argue against this? Do the authors think this is related to the specificity of the action of MitoQ, or to different sub-cellular localisation of the Nox4 and MitoQ, or some other explanation?

Based on our previous studies and those of others, we believe that Nox4 is located in the endoplasmic reticulum (e.g. Santos et al., 2016). Since MitoQ targets to the mitochondria, it is not surprising that it should have no effect on Nox4 actions in a different location. From the perspective of the overall exercise response and the effect of interventions on mitochondrial ROS, our results suggest that there is limited scope for enhancement of the adaptive exercise response in healthy adult mice with normal Nox4/Nrf2 activation, at least in the relatively acute exercise setting. However, this may be different in settings where Nox4/Nrf2 activation is impaired. We have discussed this in the penultimate paragraph of the Discussion section).

> 4\) A lack of change in cardiac Nox2 content (Figure 1---figure supplement 1) is cited as evidence for a lack of involvement of this protein in exercise responses, but Nox2 activity is regulated (differently to Nox4) by assembly and activation of the NADPH oxidase complex rather than protein content. Can this protein therefore be excluded on the basis of Nox2 content?

We agree and we therefore performed additional experiments to address this point. Please see the response in Essential Revision above.
